Further, multiple inhibitors targeting FTO such as meclofenamic acid (MA) [117], R-2-Hydroxyglutarate (R-2HG) [118], FB23, and FB23-2 [119], exert anti-cancer effects by selectively inhibiting the activity of FTO. Here, FTO is linked to cancer.